Shanxi Zhendong Pharmaceutical Co. Ltd. | Ownership
Companies that own Shanxi Zhendong Pharmaceutical Co. Ltd.
China Southern Asset Management Co., Ltd.
6,173,200
0.73%
5,947,546
0.03%
12/31/2017
Huatai-PineBridge Fund Management Co., Ltd.
5,292,158
0.62%
5,240,558
0.06%
12/31/2017
Truvalue Asset Management Co. Ltd.
841,228
0.1%
-816,556
0.03%
12/31/2017
GF Fund Management Co., Ltd.
252,200
0.03%
79,600
0%
12/31/2017
CR Yuanta Fund Management Co.,Ltd
130,000
0.02%
130,000
0.04%
12/31/2017
Rongtong Fund Management Co., Ltd.
118,552
0.01%
118,552
0%
12/31/2017
Yinhua Fund Management Co., Ltd.
21,200
0%
21,200
0%
12/31/2017
CICC Fund Management Ltd.
15,400
0%
15,400
0.01%
12/31/2017
JT Asset Management Co., Ltd.
11,400
0%
11,400
0%
12/31/2017
Zhongrong Fund Management Co. Ltd.
56
0%
-3,144
0%
12/31/2017
Address |
Zhendong Technology Park Changzhi Shanxi 047100 China
|
Employees
|
- |
Website |
http://www.zdjt.com |
Updated |
07/08/2019 |
Shanxi Zhendong Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and distribution of Chinese traditional medicines and western medicines. Its main products include Yanshu injection, Norfloxacin, Shuxuening injection, Guanxinning injection, Amoxicillin Sodium for injection, Cefathiamidine for injection, and Riboflavin Sodium Phosphate for injection. The company was founded on November 22, 1993 and is headquartered in Changzhi, China. |